Search

Your search keyword '"Marra, F. ."' showing total 63 results

Search Constraints

Start Over You searched for: Author "Marra, F. ." Remove constraint Author: "Marra, F. ." Topic medicine Remove constraint Topic: medicine
63 results on '"Marra, F. ."'

Search Results

1. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD : an individual patient data meta-analysis

2. Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications

3. Pattern of macrovascular invasion in hepatocellular carcinoma

4. Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study

5. Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice

6. Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon

7. Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study

8. Metabolic disorders across hepatocellular carcinoma in Italy

9. Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group

10. Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study

11. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

12. Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis

13. HUMAN LEUKOCYTE ANTIGEN POLYMORPHISMS IN ITALIAN PRIMARY BILIARY CIRRHOSIS: A MULTICENTER STUDY OF 664 PATIENTS AND 1992 HEALTHY CONTROLS

14. Pathway-based analysis of primary biliary cirrhosis genome-wide association studies

15. Behavior Therapy for Nonalcoholic Fatty Liver Disease: Need for a Multidisciplinary Approach

16. Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice

17. Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma

18. Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter

19. Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib

20. Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

21. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

22. The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study

23. AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions

24. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis

25. EASL recommendations on treatment of hepatitis C: Final update of the series☆

26. Alcohol use disorder and liver transplant: new perspectives and critical issues

27. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance

28. Surveillance for hepatocellular carcinoma with a 3-months interval in 'extremely high-risk' patients does not further improve survival

29. Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study

30. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease

31. Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma

32. Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients

33. Monofocal hepatocellular carcinoma: How much does size matter?

34. Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis

35. Study of energetic properties of different tree organs in six Olea europaea L. cultivars

36. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

37. PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD

38. Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives

39. Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting

40. Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD

41. Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease

42. Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF)

43. Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times

44. Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation

45. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease

46. Impact of psychosocial status on liver transplant process

47. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

48. EASL Recommendations on Treatment of Hepatitis C 2018

49. Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter

50. The evolutionary scenario of hepatocellular carcinoma in Italy: an update

Catalog

Books, media, physical & digital resources